79 related articles for article (PubMed ID: 29604204)
1. Kallikrein-related peptidases in lung diseases.
Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.
Magnen M; Gueugnon F; Guillon A; Baranek T; Thibault VC; Petit-Courty A; de Veer SJ; Harris J; Humbles AA; Si-Tahar M; Courty Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28615200
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey.
Boumali R; Urli L; Naim M; Soualmia F; Kinugawa K; Petropoulos I; El Amri C
Biochimie; 2024 Apr; ():. PubMed ID: 38608749
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Kallikrein-Related Peptidases in Nervous System Disorders.
Mella C; Figueroa CD; Otth C; Ehrenfeld P
Front Cell Neurosci; 2020; 14():166. PubMed ID: 32655372
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.
Fuhrman-Luck RA; Loessner D; Clements JA
EJIFCC; 2014 Oct; 25(3):269-81. PubMed ID: 27683474
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
[TBL] [Abstract][Full Text] [Related]
7. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
Kishibe M
J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.
Loessner D; Goettig P; Preis S; Felber J; Bronger H; Clements JA; Dorn J; Magdolen V
Expert Opin Ther Targets; 2018 Sep; 22(9):745-763. PubMed ID: 30114962
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Tailor PD; Kodeboyina SK; Bai S; Patel N; Sharma S; Ratnani A; Copland JA; She JX; Sharma A
Oncotarget; 2018 Apr; 9(25):17876-17888. PubMed ID: 29707153
[TBL] [Abstract][Full Text] [Related]
10. Tissue kallikrein regulates alveolar macrophage apoptosis early in influenza virus infection.
Magnen M; Gueugnon F; Petit-Courty A; Baranek T; Sizaret D; Brewah YA; Humbles AA; Si-Tahar M; Courty Y
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1127-L1140. PubMed ID: 30908937
[TBL] [Abstract][Full Text] [Related]
11. Description of an activity-based enzyme biosensor for lung cancer detection.
Dempsey PW; Sandu CM; Gonzalezirias R; Hantula S; Covarrubias-Zambrano O; Bossmann SH; Nagji AS; Veeramachaneni NK; Ermerak NO; Kocakaya D; Lacin T; Yildizeli B; Lilley P; Wen SWC; Nederby L; Hansen TF; Hilberg O
Commun Med (Lond); 2024 Mar; 4(1):37. PubMed ID: 38443590
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.
Tian H; Wei R; Xiao C; Fan T; Che Y; Liu T; Zheng B; Li C; He J
BMC Pulm Med; 2024 Jan; 24(1):53. PubMed ID: 38273291
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma.
Sumiya R; Yamada K; Hagiwara T; Nagasaka S; Miyazaki H; Igari T; Kawamura YI
Mol Clin Oncol; 2023 Aug; 19(2):64. PubMed ID: 37559880
[TBL] [Abstract][Full Text] [Related]
14. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.
Temerozo JR; Sacramento CQ; Fintelman-Rodrigues N; Pão CRR; de Freitas CS; Dias SSG; Ferreira AC; Mattos M; Soares VC; Teixeira L; Azevedo-Quintanilha IG; Hottz ED; Kurtz P; Bozza FA; Bozza PT; Souza TML; Bou-Habib DC
J Leukoc Biol; 2022 May; 111(5):1107-1121. PubMed ID: 35322471
[TBL] [Abstract][Full Text] [Related]
15. KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1.
Hua Q; Sun Z; Liu Y; Shen X; Zhao W; Zhu X; Xu P
Cell Death Dis; 2021 Sep; 12(10):860. PubMed ID: 34552064
[TBL] [Abstract][Full Text] [Related]
16. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases.
El Amri C
Adv Exp Med Biol; 2021; 1304():215-226. PubMed ID: 34019272
[TBL] [Abstract][Full Text] [Related]
17. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
18. High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.
Geng X; Babayeva L; Walch A; Aubele M; Groß E; Kiechle M; Bronger H; Dreyer T; Magdolen V; Dorn J
Am J Cancer Res; 2020; 10(6):1785-1792. PubMed ID: 32642290
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Gong W; Liu Y; Preis S; Geng X; Petit-Courty A; Kiechle M; Muckenhuber A; Dreyer T; Dorn J; Courty Y; Magdolen V
Mol Med; 2020 Feb; 26(1):19. PubMed ID: 32028882
[TBL] [Abstract][Full Text] [Related]
20. Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
Zhu N; Pauciulo MW; Welch CL; Lutz KA; Coleman AW; Gonzaga-Jauregui C; Wang J; Grimes JM; Martin LJ; He H; ; Shen Y; Chung WK; Nichols WC
Genome Med; 2019 Nov; 11(1):69. PubMed ID: 31727138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
